WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Drugs, Zidovudine (AZT) indications Prevent Vertical Transmission, Didanosine (ddI) side effects Optic Neuritis/ Retinal Changes, increase in ddI levels if taken with Ganciclovir, Raltegravir side effects headache, P-Glycoprotein Transporter which alters Disposition of many Drugs, Zidovudine (AZT) side effects Dose-Dependent CNS Toxicity; Myopathy, Saquinavir oral S>H, Nucleotide Reverse Transcriptase Inhibitors (NRTI) such as Tenofovir (TDF), Nucleotide Reverse Transcriptase Inhibitors (NRTI) MOA Phosphorylation by host enzymes, Didanosine (ddI) is deoxyadenosine analog, Toxic Epidermal Necrolysis (TNE) Skin Rash, increased bioavailability of Lamivudine if co-administered with TMP-SMZ, Maraviroc mutation CCR5-d32, Non-Nucleotide Reverse Transcriptase Inhibitors (NNRTI) such as Efavirenz, Ritonavir oral With Food, Empty Stomach such as Didanosine, Atazanavir side effects Hyperbilirubinemia with Overt Jaundice, Saquinavir co-administration reduces GI irritation, Didanosine (ddI) side effects asymptomatic Hyperuricemia, Entry Inhibitors such as Maraviroc